TLX Telix Pharmaceuticals Limited
Price Chart
Executive Summary
Telix Pharmaceuticals and United Imaging signed an MOU to evaluate a strategic research collaboration integrating Telix's radiopharmaceuticals with United Imaging's scanner platforms, initially focusing on TLX101-Px (Pixclara) in the U.S. The collaboration is exploratory and non-binding, with no financial terms disclosed, and does not change Telix's near-term revenue or regulatory trajectory.
Actionable Insight
This is a non-binding exploratory MOU with no financial terms — unlikely to move the stock near-term. The key catalyst for TLX remains the PDUFA date of September 11, 2026 for TLX101-Px. Monitor for any subsequent definitive agreements or expansion announcements.
Key Facts
- MOU signed with United Imaging Healthcare North America to evaluate integrated theranostics workflows.
- Initial focus on TLX101-Px (Pixclara, Floretyrosine F 18) in the U.S., with potential expansion to other products and markets.
- TLX101-Px NDA accepted by FDA in April 2026, with PDUFA goal date of September 11, 2026.
- No financial terms, revenue commitments, or binding obligations disclosed.
- Collaboration includes scanning protocol optimization, workflow tools, and pilot programs.
Financial Impact
No financial terms disclosed; collaboration is exploratory and non-binding.
Risk Factors
- MOU is non-binding and may not lead to a definitive agreement.
- TLX101-Px has not received marketing authorization in any jurisdiction; FDA decision pending.
- No revenue or cost-sharing details provided; financial impact uncertain.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3304988 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
10d ago
|
Press Release
| $9.16 $8.77 | ▼ −4.26% | ▼ −3.54% | $9.56 (+4.37%) |
|
Jun 1, 2026
11d ago
|
Press Release
| $9.16 $8.77 | ▼ −4.26% | ▼ −3.54% | $9.56 (+4.37%) |
|
May 18, 2026
25d ago
|
Press Release
| $10.17 $10.28 | ▲ +1.08% | ▲ +0.04% | $9.56 (−6.00%) |
|
May 15, 2026
28d ago
|
Press Release
| $10.56 $10.28 | ▼ −2.65% | ▼ −2.59% | $9.56 (−9.47%) |
|
May 4, 2026
5w ago
|
Press Release
| $11.04 $11.11 | ▲ +0.63% | ▼ −0.75% | $9.56 (−13.41%) |
|
Apr 29, 2026
6w ago
|
Press Release
| $11.00 $11.26 | ▲ +2.36% | ▲ +2.14% | $9.56 (−13.09%) |
|
Apr 21, 2026
7w ago
|
Press Release
| $10.33 $10.19 | ▼ −1.36% | ▼ −0.96% | $9.56 (−7.45%) |
|
Apr 13, 2026
8w ago
|
Press Release
| $11.24 $10.70 | ▼ −4.80% | ▼ −6.01% | $9.56 (−14.95%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access